Clinical Trials in Central and Eastern Europe

 

Opera Consortium will attend the conference Clinical Trials in Central and Eastern Europe from 25 – 26 April 2017, at Novotel Budapest Centrum.

Last year’s Clinical Trials in CEE Forum hosted more than 130 delegates from following countries:

Belgium • Poland • Slovakia • Slovenia • Croatia • Czech Republic • Germany
Italy • Romania • Ukraine • United Kingdom • Armenia • Bulgaria • Finland
Hungary • Latvia • Lithuania • Netherlands • Russian Federation • Spain
Switzerland • United States

This conference will provide up-to-date information about Clinical Trials in the region, the industry best practice and will create platform for information to be exchanged between Government official, CROs, Investigations & Biotechnological companies and Clinical trials professionals. As well as a carefully researched and in-depth programme, the conferences will bring you the opportunity to network with a diverse mix of participants, through our structured and less-formal networking sessions.

Some of the Speakers 2017:

  • Csilla Pozsgay- Director General National Institute of Pharmacy and Nutrition (Hungary)
  • Francis Crawley- Executive Director Good Clinical Practice Alliance, Europe & EAP, Belgium
  • Divya Chadha- Head of Business Development, CRN
  • Alexander Fetkovsky- Managing Partner, Slovak Republic
  • Marco Salami- Sr Clinical Outsourcing Manager, Chiesi Farmaceutici SpA (Italy)
  • Vladimir Misik- Founder & Managing Partner, LongTaal
  • Rahul Chaudhary- Director Business Development- Histopathology, Synevo Division
  • Jaroslav Rejnek- Clinical Research Director, PENTA Hospitals
  • Michaela Vancova- Clinical Operations Director, Co-Founder, Slovak Research Center
  • Tomasz Miszalski Jamka- MD, PhD, Medical Director, Clinical Trial Center of Innovation
  • Gjon Mirdita- Vice President, Site Management Regional Head, Key Markets R&D Solutions NEMEA & CESE, QuintilesIMS

The Forum’s key questions and takeaways

  • What is the regulatory outlook across the region?
  • What would facilitate and empower an Investigator?
  • How to maximise the Sponsor/CRO/Investigator relationship and cooperation?
  • How to stimulate patient recruitment and ensure patient retention? What are the patient-centric approaches in CT?
  • What are the innovative approaches to trial design?